medAI Times

medAI Times

medAI Times is a daily podcast on artificial intelligence in medicine. Each short episode delivers concise, credible, clinically focused updates on AI research, medical imaging, drug discovery, clinical decision support, large language models in healthcare, regulation, ethics, and digital health. Built for clinicians, researchers, students, and healthcare professionals who want to stay current without wading through noise. We cite sources, separate peer-reviewed evidence from preprints and announcements, and avoid hype. New episodes daily. For educational and informational purposes only. Not medical advice.

  1. Oct 23

    Claude Designed 17 Scorpion Toxin Binders in 64 Hours — Oct 23, 2026

    Claude designed three hundred thousand proteins in sixty-four hours. Seventeen worked. Run time: 6:30 In today's episode: Claude designs 17 scorpion toxin binders; no antivenom yetOpenAI swarm of 2,000 agents mines mouse brain atlasFace-photo AI predicts cancer survival in Lancet Digital HealthFDA clears TumorSight Risk for breast recurrence estimatesFDA clears Elucid FFR-IQ for CT-based coronary flowAstraZeneca-insitro deal: $40M upfront, $1.5B headlineFDA generative AI device comment window closesAnthropic opens Claude Duet agent to waitlistAnthropic draft IPO papers leak revenue and lossTL;DR: Claude's scorpion-toxin binders are real lab hits (17 of 211) but only binding data: no neutralization, no venom, no animals.OpenAI's agent swarm produced a DCTN1-cholesterol lead from a mouse brain atlas; preprint, company-authored, unconfirmed at the bench.Two FDA clearances (TumorSight Risk, Elucid FFR-IQ) rest on company validation that shows consistency, not outcome benefit.Sources cited: AnthropicThe DecoderbioRxiv preprintpress releaseTech TimesNews-MedicalFox affiliate report of company releaseCardiovascular BusinessFierce BiotechFDASubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  2. Oct 16

    ChatGPT Sued by 8 States Over Kids and Medical Advice — Oct 16, 2026

    Eight states just took ChatGPT to court, and medical advice is in the complaint. Run time: 7:07 In today's episode: Eight states sue OpenAI; the FTC sends demands to OpenAI and AnthropicChatbots miss GI emergencies far more often outside EnglishPenn patients text their EEG monitors in Nature MedicineDeepMind agent finds an antibiotic candidate; wet lab pendingZealand pays Generate $30M up front for AI-designed proteinsOpenEvidence goes live in Northwestern's Epic and signs HopkinsUnitedHealth says AI chart summaries reach 40% of its cliniciansFOLLOW-UP: UK accepts all 44 health AI regulation recommendationsMeta releases Muse Spark Open, 816B open weightsNEW: Anthropic embeds six METR evaluators with publication rightsTL;DR: Eight states (October 14) and the FTC (October 14, reported October 15) moved against frontier chatbot makers in the same 24 hours. The states' complaints name harmful medical guidance and a claimed overdose. All of it is allegation so far.An ACG abstract found four small chatbots failed to advise emergency care in 15% of English answers and about 40% of Chinese and Vietnamese ones. It's the most clinically useful number of the week, from the weakest kind of source.The week's AI biology "discovery" (DeepMind's bacteriocin) is computational only. The AI drug money (Zealand and Generate) is real, but $30M of it is up front and the rest is milestones.Sources cited: EngadgetThe New DailyGizmodo (FTC)HealioPenn MedicineGoogle DeepMindBioSpaceHealthcare IT NewsNorthwesternUnite.AI (Hopkins)Subscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  3. Oct 9

    Google's AI Chatbot Saw 100 Real Patients in a Lancet Study — Oct 9, 2026

    Can a chatbot safely interview real patients before the doctor does? Google just tested it. Run time: 7:28 In today's episode: Google's AMIE chatbot interviews 100 real patients, Lancet reportsKFF: Medicare-run Slack gave health-AI industry inside accessFDA's 2027 agenda: finish AI lifecycle guidance, draft chatbot rulesFOLLOW-UP: Utah's AI prescribing pilots may collide with FDAClairity breast cancer risk AI goes direct to consumersMoleMap: AI-assisted nurses flag more skin cancers, unrandomizedXaira posts first hit rates for AI-designed antibodiesOpenAI posts 372 math result families; mathematicians can't read themNEW: Claude Haiku 5.5 at ten cents per million tokensNEW: Anthropic commits $150 million to federal Genesis MissionThree fired OpenAI safety researchers dispute misconduct claimsTL;DR: Google's AMIE reached real patients, in The Lancet (Oct 8). 100 adults at a Beth Israel Deaconess urgent primary care clinic, a physician watching every chat, zero safety stops, final diagnosis in the differential 90% of the time. Single arm, single centre: feasibility, not benefit.OpenAI published 372 families of AI-generated math results (Oct 6), including a claimed proof of the Unique Games Conjecture. About 42% of top-line results are Lean-checked, and the people best placed to read the proofs say they can't yet.Health-AI policy is being shaped in rooms the public can't see. KFF Health News (Oct 9) documents a 1,700-member CMS-run Slack and an unlisted FDA listening session on patient chatbots, the same week the FDA put generative-AI mental health devices on its 2027 guidance agenda.Sources cited: The LancetGoogle blogpreprint, arXiv 2603.08448KFF Health NewsCBS NewsMedTech DiveRAPSSTATHealth Affairs Forefront backgroundEverlywell release via Yahoo FinanceSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  4. Oct 2

    California Just Banned AI From Making Clinical Decisions — Oct 2, 2026

    California just made it law: AI can advise your nurse, not replace them. Run time: 6:35 In today's episode: California law limits hospital AI to advice, not decisionsRFK Jr. says AI beats any doctor as second opinionSynthetic Hospital fools physicians, stumps ten AI modelsHarrison.ai head CT tool tested on 3,424 ED scansHeidi II moves scribe AI into referrals and follow-upsUltrasound-video AI lifts junior radiologists on lymph nodesAI "ECG age" refines stroke risk in borderline AFHHS launches SURPASS to rebuild clinical trials with AIGoogle ships Gemini 4 Argon, cyber defenders firstNEW: Claude Sonnet 5.5, same price, fasterLeaked Anthropic prospectus shows cloud-partner dependenceTL;DR: California signed AB 1979 (Sept 30): AI cannot independently perform clinical functions reserved for licensed professionals, effective in 2027. Newsom vetoed AB 2575, the bill that would have protected clinicians who overrule an algorithm.The federal government is sending the opposite signal. HHS Secretary Kennedy called AI a second opinion "better informed than any doctor" (Sept 29), and HHS/ARPA-H launched SURPASS to speed trials with AI (Sept 30).Evidence this week was mostly middling: a strong open benchmark (Synthetic Hospital, preprint), a retrospective head-CT validation, and several vendor launches with no outcome data.Sources cited: CalMattersGovernor's officeNational Nurses UnitedYahoo NewsNewsweekarXiv 2609.30027GitHubEmergency Medicine Australasia, DOI 10.1111/1742-6723.70353Fierce HealthcareRadiology: AI, DOI 10.1148/ryai.260131Subscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  5. Sep 25

    Blue Cross: Hospital AI Added $942 Million in Bills — Sep 25, 2026

    Hospital A I added nearly a billion dollars in charges. Nobody got sicker. Run time: 7:28 In today's episode: Blue Cross: hospital AI added $942 million in chargesVA picks Abridge for ambient AI, $775.7M ceilingAllina doctors win first contract after AI-fueled strikeAnthropic, OpenEvidence give clinical AI to 100 countriesClaude flags a new CRISPR-adjacent enzyme systemPhone app separates Crohn's from intestinal TBUNC and Duke launch rural AI network for North CarolinaOnly a third of brain-imaging AI studies externally validatedNEW: Claude Opus 5.5 ships, 40% cheaper than Opus 5OpenAI releases GPT-6 Sol and Luna, prices halvedGemini 4 confirmed in post-trainingTL;DR: Blue Cross insurers measured $942 million in added charges over two years and attribute it to AI-assisted coding and ambient scribes documenting conditions patients weren't treated for — an insurer analysis, not peer-reviewed, but the largest dollar figure yet put on ambient AI's billing side effect.The VA bought ambient AI nationwide anyway, under a five-year enterprise contract with a $775.7M ceiling covering 9M+ veterans across both its record systems.Anthropic had a loud week in medicine: free OpenEvidence access for ~100 low- and middle-income countries, a claimed novel enzyme system that CRISPR researchers are calling routine, and Opus 5.5 with biology capability locked behind a vetting program.Sources cited: PYMNTSHIT ConsultantMPR NewsThe Next WebAnthropicroutine genome miningAliment Pharmacol TherUNC HealthJ Imaging Inform MedAnthropicSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  6. Sep 18

    Medicare's AI Left Patients Waiting 83 Days — Sep 18, 2026

    One Medicare patient waited eighty-three days for their AI reviewer to answer. Run time: 7:10 In today's episode: Medicare's AI prior-auth pilot denied care, delayed one case 83 daysFDA final order: AI radiology software still needs premarket clearanceGemini, ChatGPT, and Claude all fail a heart-attack screening testFirst AI-discovered drug doses first patient in a Phase 3 trialMIT and Harvard debut real-time AI X-ray-to-CT navigation toolMeta-analysis: AI hits 93% sensitivity on pediatric wrist fracturesMedtronic's Hugo surgical robot gets a new FDA-cleared instrumentAnthropic: Claude now leads 26% of its own R&DOpenAI discloses six AI models that misbehaved, adds disclosure rulesTL;DR: Medicare's AI-driven prior-authorization pilot denied thousands of requests and left one patient waiting 83 days, per new FOIA documents — a real-world case study for outcome-based AI oversight, not just one-time clearance.Three general-purpose chatbots (Gemini, ChatGPT, Claude) failed to reliably flag real heart attacks from prehospital ECGs, while the FDA doubled down on requiring full premarket review for AI radiology software updates.The first AI-discovered drug (Insilico's rentosertib) entered Phase 3 trials, and Anthropic says Claude now leads 26% of its own R&D — two data points on how fast "AI building AI" is moving, in the clinic and in the lab.Sources cited: STAT NewsPYMNTSHeart & LungInsilico MedicineNatureEmergency RadiologyMedTech DiveWashington PostAxiosFDA's AI-enabled medical device listSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  7. Sep 14

    DeepMind's AlphaGenome Maps Every DNA Mutation — Sep 14, 2026

    Google just mapped every possible way a single DNA letter can go wrong. Run time: 7:23 In today's episode: DeepMind maps all 9 billion possible DNA mutationsUK proposes 44 new rules for medical AIRural AI push meets skepticism from actual providersOpenEvidence restricts its best model over dual-use riskAI spots collapsed lungs in newborns, 87.6% sensitivityAI-measured organ volume linked to kidney cancer survivalClaude Fable 5.1 and Mythos 5.1 go liveGPT-6 Astra rated "critical" cyber risk by OpenAITL;DR: DeepMind released the AlphaGenome Atlas, a free public database predicting the biological effect of all 9 billion possible single-letter DNA changes — built with Broad, Harvard, and Boston Children's, with DeepMind's own caveat that it is not clinically validated.The UK's National Commission into AI in Healthcare published 44 recommendations after consulting over 12,000 clinicians and patients, proposing a shift from one-time device clearance to lifecycle monitoring plus a patient's right to know when AI is used in their care.OpenEvidence launched a four-model family and restricted its top model, Darwin, which the company says scored 100% on the MedQA licensing-exam benchmark, citing dual-use risk.Sources cited: Google DeepMindGOV.UKOpenEvidenceSTAT NewsPediatric RadiologyAnnals of MedicineAnthropicOpenAISubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  8. Jul 27

    Should You Ask AI or Your Doctor? 2026 Evidence — Jul 27, 2026

    Chatbots beat doctors on paper. Then real patients used them and it fell apart. Run time: 6:50 In today's episode: Chatbot answers rated more empathetic than doctors, preferred 79% of the timeGPT-4 alone beat physicians by ~15 points on diagnostic vignettesGoogle's AMIE matched or beat primary care docs in text consultationsMicrosoft's system solved 85% of hard NEJM cases vs doctors' 20%Oxford RCT: patients using LLMs did no better than a web searchHalf of consumer chatbot medical advice carried potential for harm~1 in 6 US adults now use an AI chatbot for health advice monthlyTL;DR: On clean written cases, AI genuinely out-diagnoses doctors — that part is peer-reviewed, not hype.On real patients doing their own typing, that edge vanishes: an Oxford RCT (~1,300 people) found LLM users did no better than web search, because patients omit the detail that matters and models mix right advice with wrong.What's actually deployed is the opposite of a doctor replacement: clinician tools like OpenEvidence (used by ~65% of US doctors) keep a licensed human between the model and the prescription. No LLM is FDA-cleared to diagnose you solo.Sources cited: JAMA Internal Medicine, Ayers et al.JAMA Network Open, Goh et al.Nature, Google DeepMindMicrosoft AIOxford, Nuffield Dept of Primary Care (Payne et al.)NBC News on OpenEvidenceSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

About

medAI Times is a daily podcast on artificial intelligence in medicine. Each short episode delivers concise, credible, clinically focused updates on AI research, medical imaging, drug discovery, clinical decision support, large language models in healthcare, regulation, ethics, and digital health. Built for clinicians, researchers, students, and healthcare professionals who want to stay current without wading through noise. We cite sources, separate peer-reviewed evidence from preprints and announcements, and avoid hype. New episodes daily. For educational and informational purposes only. Not medical advice.

You Might Also Like